Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis.
|
22195034 |
2011 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Patients with heterozygous STAT1 gain-of-function (GOF) mutations usually present with chronic mucocutaneous candidiasis (CMC) but may also experience bacterial and viral infections, autoimmune manifestations, lymphopenia, cerebral aneurysms, and increased risk to develop tumors.
|
27803128 |
2017 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Signal transducer and activator of transcription 1 (STAT-1) gain-of-function (GOF) mutations cause chronic mucocutaneous candidiasis (CMC), a disease associated with Candida albicans and Staphylococcus aureus infection.
|
30069986 |
2018 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Conversely, the few known activating mutations of STAT1 allow predisposition to chronic mucocutaneous candidiasis disease, and occur in patients with combined immunodeficiency and defective Th1 and Th17 responses.
|
31448411 |
2019 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.
|
26494717 |
2015 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis.
|
26494717 |
2015 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Human signal transducer and activator of transcription 1 (STAT1) gain-of-function (GOF) mutations present with a broad range of manifestations ranging from chronic mucocutaneous candidiasis and autoimmunity to combined immunodeficiency (CID).
|
30543054 |
2019 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Signal transducer and activator of transcription 1 gain-of-function (STAT1 GOF) mutations are the most common cause of chronic mucocutaneous candidiasis (CMC).
|
29934865 |
2018 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Two novel gain-of-function mutations of STAT1 responsible for chronic mucocutaneous candidiasis disease: impaired production of IL-17A and IL-22, and the presence of anti-IL-17F autoantibody.
|
25288569 |
2014 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Gain-of-function STAT1 mutations impair STAT3 activity in patients with chronic mucocutaneous candidiasis (CMC).
|
26255980 |
2015 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Dominant gain-of-function mutations in signal transducer and activator of transcription 1 (STAT1) have been associated with chronic mucocutaneous candidiasis.
|
23541320 |
2013 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis due to Gain-of-Function Mutations in STAT1.
|
26604104 |
2016 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Since their discovery in patients with autosomal dominant (AD) chronic mucocutaneous candidiasis (CMC) in 2011, heterozygous STAT1 gain-of-function (GOF) mutations have increasingly been identified worldwide.
|
27114460 |
2016 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
|
23709754 |
2013 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
Biomarker
|
disease |
HPO |
|
|
|
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous gain-of-function (GOF) mutations in the signal transducer and activator of transcription 1 (STAT1) have increasingly been identified as a genetic cause of autosomal-dominant (AD) chronic mucocutaneous candidiasis (CMC).
|
28597685 |
2017 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis.
|
21727188 |
2011 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Heterozygous STAT1 gain-of-function (GOF) mutations result in a combined form of immunodeficiency which is the most common genetic cause of chronic mucocutaneous candidiasis (CMC).
|
31637766 |
2020 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Chronic mucocutaneous candidiasis: characterization of a family with STAT-1 gain-of-function and development of an ex-vivo assay for Th17 deficiency of diagnostic utility.
|
26621323 |
2016 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Heterozygosity for loss-of-function dominant-negative mutations in STAT1 is responsible for autosomal dominant (AD) Mendelian susceptibility to mycobacterial disease (MSMD), whereas heterozygosity for gain-of-function loss-of-dephosphorylation mutations causes AD chronic mucocutaneous candidiasis (CMC).
|
22573496 |
2012 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Autosomal dominant gain of function STAT1 mutation and severe bronchiectasis.
|
28427548 |
2017 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autosomal-dominant chronic mucocutaneous candidiasis with STAT1-mutation can be complicated with chronic active hepatitis and hypothyroidism.
|
22847544 |
2012 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
CausalMutation
|
disease |
CLINVAR |
Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis.
|
23541320 |
2013 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Recently, gain-of-function (GOF) mutations in the gene encoding signal transducer and activator of transcription 1 (STAT1) have been associated with chronic mucocutaneous candidiasis (CMC).
|
27063510 |
2016 |
Candidiasis, Chronic Mucocutaneous
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
STAT1 GOF mutations were described as the major cause of chronic mucocutaneous candidiasis, while activating STAT3 mutations result in early-onset multiorgan autoimmunity and ID.
|
30407975 |
2018 |